Atle Fund Management AB

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1381843 STOCKHOLM, V7

Position in VRTX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$10,263,275

-$156,751 QoQ

Shares Held

22,984

0.0% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

2.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Atle Fund Management AB holds $202,705,517 across 20 Biotechnology names. VRTX ranks #7 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	617,245	$60,027,076
2	BCAX	Bicara Therapeutics Inc.	1,169,634	$23,264,020
3	MIRM	Mirum Pharmaceuticals, Inc.	195,768	$18,085,047
4	CELC	Celcuity Inc.	141,296	$16,127,525
5	INSM	INSMED Inc	97,438	$15,933,061
6	ONC	BeOne Medicines Ltd.	41,717	$12,388,697
7	VRTX	Vertex Pharmaceuticals Inc / Ma This page	22,984	$10,263,275
8	KRYS	Krystal Biotech, Inc.	37,579	$9,707,407

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,263,275	22,984	0.0%	Shares	Sole	2026-05-11
2025-12-31	$10,420,026	22,984	+29.4%	Shares	Sole	2026-02-06
2025-09-30	$6,957,876	17,766	-27.0%	Shares	Sole	2025-11-04
2025-06-30	$10,830,825	24,328	+6.7%	Shares	Sole	2025-07-14
2025-03-31	$11,057,774	22,808	+2.5%	Shares	Sole	2025-05-05
2024-12-31	$8,962,893	22,257	+31.0%	Shares	Sole	2025-02-04
2024-09-30	$7,903,104	16,993	+12.6%	Shares	Sole	2024-11-12
2024-06-30	$7,075,328	15,095	+33.6%	Shares	Sole	2024-08-14
2024-03-31	$4,721,422	11,295	+23.7%	Shares	Sole	2024-04-25
2023-12-31	$3,714,905	9,130	+4126.9%	Shares	Sole	2024-01-30
2022-12-31	$62,376	216	-99.6%	Shares	Sole	2023-02-14
2021-06-30	$10,484,760	52,000	+48.6%	Shares	Sole	2021-08-10
2021-03-31	$7,521,150	35,000	—	Shares	Sole	2021-04-30
No filing history on record for this holder in this stock.